Carcinogenesis, Vol. 20, No. 3, 353-368,
March 1999
© 1999 Oxford University Press
Review |
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Department of Pathology, Medical College of Ohio, Toledo, OH 43614-5806 and
1 Chemical Carcinogenesis Section, Laboratory of Experimental Carcinogenesis, Division of Basic Sciences, National Cancer Institute, Building 37, Room 3C28, 37 Convent Drive MSC 4255, Bethesda, MD 20892-4255, USA
The heterocyclic amines (HCAs) are a family of mutagenic/carcinogenic compounds produced during the pyrolysis of creatine, amino acids and proteins. The major subclass of HCAs found in the human diet comprise the aminoimidazoazaarenes (AIAs) 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). All, except DiMeIQx, have been shown to be carcinogenic in animals. These compounds are present in cooked muscle meats at the p.p.b. level. Since the discovery of the HCAs in the late 1970s, many studies have examined the DNA adducts of these compounds. This review compiles the literature on AIA–DNA adducts including their identification and characterization, pathways of formation, mutagenesis in vitro and in vivo, and their association with carcinogenesis in animal models. It is now known that metabolic activation leading to the formation of DNA adducts is critical for mutagenicity and carcinogenicity of these compounds. All of the AIAs studied adduct to the guanine base, the major adduct being formed at the C8 position. Two AIAs, IQ and MeIQx, also form minor adducts at the N2 position of guanine. A growing body of literature has reported on the mutation spectra induced by AIA–guanine adducts. Studies of animal tumors induced by AIAs have begun to relate AIA–DNA adduct-induced mutagenic events with the mutations found in critical genes associated with oncogenesis. Several studies have demonstrated the feasibility of chemoprevention of AIA tumorigenesis. Only a few studies have reported on the detection of AIA–DNA adducts in human tissues; difficulties persist in the routine detection of AIA–DNA adducts in humans for the purpose of biomonitoring of exposure to AIAs. The AIAs are nevertheless regarded as possible human carcinogens, and future research on AIA–DNA adducts is likely to help address the role of AIAs in human cancer.
Abbreviations: AIA, aminoimidazoazaarene; AMS, accelerator mass spectrometry; BcPHDE, benzo[c]phenanthrene diol epoxide; CHL, chlorophyllin; CLA, conjugated linoleic acid; DiMeIQx, 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline; dG-C8–IQ, N-(deoxyguanosin-8-yl)–IQ; dG-C8–MeIQ, N-(deoxyguanosin-8-yl)–MeIQ; dG-C8–MeIQx, N-(deoxyguanosin-8-yl)–MeIQx; dG-N2–MeIQx, 5'-(deoxyguanosin-N2-yl)–MeIQx; dG-C8-4,8–DiMeIQx, N-(deoxyguanosin-8-yl)-4,8–DiMeIQx; dG-C8–PhIP, N-(deoxyguanosin-8-yl)–PhIP; dG-N2–IQ, 5'-(deoxyguanosin-N2-yl)–IQ; GC–MS, gas chromatography–mass spectrometry; HCA, heterocyclic amine; I3C, indole-3-carbinol; IQ, 2-amino-3-methylimidazo[4,5-f]quinoline; MeIQ, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline; MeIQx, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline; NAT, N-acetyltransferase; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; WBC, white blood cell.
2 To whom correspondence should be addressed Email: elizabeth_snyderwine{at}nih.gov
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. J. Metry, J. R. Neale, J. Bendaly, N. B. Smith, W. M. Pierce Jr., and D. W. Hein Effect of N-Acetyltransferase 2 Polymorphism on Tumor Target Tissue DNA Adduct Levels in Rapid and Slow Acetylator Congenic Rats Administered 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Drug Metab. Dispos., November 1, 2009; 37(11): 2123 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fukuda, T. Takamura-Enya, Y. Masuda, T. Nohmi, C. Seki, K. Kamiya, T. Sugimura, C. Masutani, F. Hanaoka, and H. Nakagama Translesional DNA Synthesis through a C8-Guanyl Adduct of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 INSERTS dC OPPOSITE THE LESION, AND DNA POLYMERASE {kappa} POTENTIALLY CATALYZES EXTENSION REACTION FROM THE 3'-dC TERMINUS J. Biol. Chem., September 18, 2009; 284(38): 25585 - 25592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Najafzadeh, P. D. Reynolds, A. Baumgartner, and D. Anderson Flavonoids inhibit the genotoxicity of hydrogen peroxide (H2O2) and of the food mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD) Mutagenesis, September 1, 2009; 24(5): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koutros, S. I. Berndt, R. Sinha, X. Ma, N. Chatterjee, M. C.R. Alavanja, T. Zheng, W.-Y. Huang, R. B. Hayes, and A. J. Cross Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate Cancer Cancer Res., March 1, 2009; 69(5): 1877 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Rosenberg, C. Giardina, and T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis, February 1, 2009; 30(2): 183 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Lam, A. J. Cross, D. Consonni, G. Randi, V. Bagnardi, P. A. Bertazzi, N. E. Caporaso, R. Sinha, A. F. Subar, and M. T. Landi Intakes of Red Meat, Processed Meat, and Meat Mutagens Increase Lung Cancer Risk Cancer Res., February 1, 2009; 69(3): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. B. Okey, and P. A. Harper Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3098 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Lauber and N. J. Gooderham The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer Cancer Res., October 1, 2007; 67(19): 9597 - 9602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bendaly, S. Zhao, J. R. Neale, K. J. Metry, M. A. Doll, J. C. States, W. M. Pierce Jr., and D. W. Hein 2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline-Induced DNA Adduct Formation and Mutagenesis in DNA Repair-Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ma, J. R. Idle, M. A. Malfatti, K. W. Krausz, D. W. Nebert, C.-S. Chen, J. S. Felton, D. J. Waxman, and F. J. Gonzalez Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2007; 28(3): 732 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakai, W. G. Nelson, and A. M. De Marzo The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate Cancer Res., February 1, 2007; 67(3): 1378 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wu, E. Giovannucci, C. Byrne, E. A. Platz, C. Fuchs, W. C. Willett, and R. Sinha Meat mutagens and risk of distal colon adenoma in a cohort of u.s. Men. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1120 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishikawa-Ogawa, H. Wanibuchi, K. Morimura, A. Kinoshita, T. Nishikawa, S. Hayashi, Y. Yano, and S. Fukushima N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage Carcinogenesis, May 1, 2006; 27(5): 982 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Stover, C. E. Elmquist, F. Wang, H. Zang, M. P. Stone, F. P. Guenegerich, and C. J. Rizzo Synthesis, Conformation, and By-Pass of Carcinogen-Modified Oligonucleotides Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 207 - 210. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Okamura, M. Moto, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice Toxicol Pathol, February 1, 2006; 34(2): 199 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Singh and P. B. Farmer Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection Carcinogenesis, February 1, 2006; 27(2): 178 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Bachman, J. Sager, I. Cheong, M. Catto, A. Bardelli, B. H. Park, B. Vogelstein, A. Carotti, K. W. Kinzler, and C. Lengauer Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells Mol. Cancer Ther., June 1, 2005; 4(6): 1026 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. J. Gillet, J. Alzeer, and O. D. Scharer Site-specific incorporation of N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-AAF) into oligonucleotides using modified 'ultra-mild' DNA synthesis Nucleic Acids Res., April 6, 2005; 33(6): 1961 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishikawa, T. Imazawa, Y. Kuroiwa, Y. Kitamura, K. Kanki, Y. Ishii, T. Umemura, and M. Hirose Induction of Colon Tumors in C57BL/6J Mice Fed MeIQx, IQ, or PhIP Followed by Dextran Sulfate Sodium Treatment Toxicol. Sci., April 1, 2005; 84(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Creton, H. Zhu, and N. J. Gooderham A Mechanistic Basis for the Role of Cycle Arrest in the Genetic Toxicology of the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Toxicol. Sci., April 1, 2005; 84(2): 335 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shan, M. Yu, and E. G. Snyderwine Gene expression profiling of chemically induced rat mammary gland cancer Carcinogenesis, February 1, 2005; 26(2): 503 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Murtaugh, C. Sweeney, K.-n. Ma, B. J. Caan, and M. L. Slattery The CYP1A1 Genotype May Alter the Association of Meat Consumption Patterns and Preparation with the Risk of Colorectal Cancer in Men and Women J. Nutr., February 1, 2005; 135(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shan, M. Yu, H. A.J. Schut, and E. G. Snyderwine Susceptibility of Rats to Mammary Gland Carcinogenesis by the Food-Derived Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) Varies with Age and Is Associated with the Induction of Differential Gene Expression Am. J. Pathol., July 1, 2004; 165(1): 191 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Glatt, U. Pabel, W. Meinl, H. Frederiksen, H. Frandsen, and E. Muckel Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeA{alpha}C) in recombinant test systems expressing human xenobiotic-metabolizing enzymes Carcinogenesis, May 1, 2004; 25(5): 801 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hikosaka, M. Asamoto, N. Hokaiwado, K. Kato, K. Kuzutani, K. Kohri, and T. Shirai Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2004; 25(3): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhu, P. Chang, M. L. Bondy, A. A. Sahin, S. E. Singletary, S. Takahashi, T. Shirai, and D. Li Detection of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]-Pyridine-DNA Adducts in Normal Breast Tissues and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 830 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Fretland, U. S. Devanaboyina, M. A. Doll, S. Zhao, G. H. Xiao, and D. W. Hein Metabolic Activation of 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian Hamsters Congenic at the N-Acetyltransferase 2 (NAT2) Locus Toxicol. Sci., August 1, 2003; 74(2): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Goldman and P. G. Shields Food Mutagens J. Nutr., March 1, 2003; 133(3): 965S - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Snyderwine, H.-S. Yoon, L. P. Knight-Jones, M. Tran, H. A.J. Schut, and M. Yu Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture Mutagenesis, January 1, 2003; 18(1): 7 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu and E. G. Snyderwine H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer Carcinogenesis, December 1, 2002; 23(12): 2123 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.G. Stillwell, R. Sinha, and S.R. Tannenbaum Excretion of the N2-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans Carcinogenesis, May 1, 2002; 23(5): 831 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murata and S. Kawanishi Oxidation of 5'-site guanine at GG and GGG sequences induced by a metabolite of carcinogenic heterocyclic amine PhIP in the presence of Cu(II) and NADH Carcinogenesis, May 1, 2002; 23(5): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu, M. L. Jones, M. Gong, R. Sinha, H. A.J. Schut, and E. G. Snyderwine Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets Carcinogenesis, May 1, 2002; 23(5): 877 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tavan, C. Cayuela, J.-M. Antoine, G. Trugnan, C. Chaugier, and P. Cassand Effects of dairy products on heterocyclic aromatic amine-induced rat colon carcinogenesis Carcinogenesis, March 1, 2002; 23(3): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Futakuchi, M. Hirose, K. Imaida, S. Takahashi, K. Ogawa, M. Asamoto, T. Miki, and T. Shirai Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats Carcinogenesis, February 1, 2002; 23(2): 283 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ubagai, M. Ochiai, T. Kawamori, H. Imai, T. Sugimura, M. Nagao, and H. Nakagama Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet Carcinogenesis, January 1, 2002; 23(1): 197 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shan, S. A. Rouhani, H. A. J. Schut, and E. G. Snyderwine 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Modulates Lactogenic Hormone-mediated Differentiation and Gene Expression in HC11 Mouse Mammary Epithelial Cells Cell Growth Differ., December 1, 2001; 12(12): 649 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts Cancer Res., December 1, 2001; 61(24): 8689 - 8696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Stuart, J. G. de Boer, R. Haesevoets, J. Holcroft, J. Kangas, K. Sojonky, E. Thorleifson, A. Thornton, D. F. Walsh, H. Yang, et al. Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats Mutagenesis, September 1, 2001; 16(5): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Gooderham, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, K. Zhao, A. R. Boobis, and D. S. Davies Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans Drug Metab. Dispos., April 1, 2001; 29(4): 529 - 534. [Abstract] [Full Text]
|
|
|
|
|
|
J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Nelson, L. C. R. Kidd, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, J. D. Groopman, W. G. Nelson, and T. W. Kensler Protection against 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cytotoxicity and DNA Adduct Formation in Human Prostate by Glutathione S-Transferase P1 Cancer Res., January 1, 2001; 61(1): 103 - 109. [Abstract] [Full Text]
|
|
|
|
|
|
K.-i. Masumura, K. Matsui, M. Yamada, M. Horiguchi, K. Ishida, M. Watanabe, K. Wakabayashi, and T. Nohmi Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases Carcinogenesis, November 1, 2000; 21(11): 2049 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Williams, F.L. Martin, G.H. Muir, A. Hewer, P.L. Grover, and D.H. Phillips Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue Carcinogenesis, September 1, 2000; 21(9): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Gressani, S. Leone-Kabler, M. G. O'Sullivan, A. J. Townsend, and M. S. Miller Prenatal Toxicity and Lack of Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) following Transplacental Exposure Toxicol. Sci., June 1, 2000; 55(2): 407 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Frandsen and J. Alexander N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, June 1, 2000; 21(6): 1197 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Snyder and M. S. Diehl The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents Mutagenesis, May 1, 2000; 15(3): 203 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marczylo, S. Arimoto-Kobayashi, and H. Hayatsu Protection against Trp-P-2 mutagenicity by purpurin: mechanism of in vitro antimutagenesis Mutagenesis, May 1, 2000; 15(3): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Williams, E. M. Stone, B. C. Millar, A. Hewer, and D. H. Phillips Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts Mutagenesis, March 1, 2000; 15(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Stuart, J. Holcroft, J. G. de Boer, and B. W. Glickman Prostate Mutations in Rats Induced by the Suspected Human Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cancer Res., January 1, 2000; 60(2): 266 - 268. [Abstract] [Full Text]
|
|